18F标记半乳糖树状单元在过表达半乳凝素-1的原位膀胱癌模型中的PET/CT显像
研究将半乳糖树状碳水化合物标记18F(18F标记半乳糖树状单元4),在表达半乳凝素的UMUC3原位膀胱癌模型中经膀胱内给药后行PET显像。结果显示该放射性示踪剂在过表达半乳凝素-1的UMUC3原位肿瘤中特异性聚集,而在非肿瘤小鼠膀胱中未聚集。作者认为该示踪剂及类似物可能具有临床相关性,可用于过表达半乳凝素-1膀胱肿瘤的PET显像。
要点
- 18F标记半乳糖树状单元4经膀胱内给药后,在过表达半乳凝素-1的UMUC3原位膀胱癌模型中PET显像可见特异性聚集。
- 该示踪剂在非肿瘤小鼠膀胱中未发现聚集。
- 作者认为该示踪剂及类似物可能具有临床相关性,可用于过表达半乳凝素-1膀胱肿瘤的PET显像。
核心结论
- 18F标记半乳糖树状单元4及类似物可能具有临床相关性,可用于过表达半乳凝素-1膀胱肿瘤的PET显像。
研究设计与样本
- 研究由18F标记半乳糖树状单元4的甲苯磺酸酯前体获得该示踪剂。
- 在表达半乳凝素的UMUC3原位膀胱癌模型中开展体内研究,以确定18F标记半乳糖树状单元4对膀胱癌显像的能力。
主要发现
- 经膀胱内给予18F标记半乳糖树状单元4后,PET显像显示该碳水化合物放射性示踪剂在过表达半乳凝素-1的UMUC3原位肿瘤中特异性聚集。
- 18F标记半乳糖树状单元4未发现聚集于非肿瘤小鼠膀胱。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Galectins are carbohydrate-binding proteins overexpressed in bladder cancer (BCa) cells. Dendritic galactose moieties have a high affinity for galectin-expressing tumor cells. We radiolabeled a dendritic galactose carbohydrate with 18F (18F-labeled galactodendritic unit 4) and examined its potential in imaging urothelial malignancies. Methods: The 18F-labeled first-generation galactodendritic unit 4 was obtained from its tosylate precursor. We conducted in vivo studies in a galectin-expressing UMUC3 orthotopic BCa model to determine the ability of 18F-labeled galactodendritic unit 4 to image BCa. Results: Intravesical administration of 18F-labeled galactodendritic unit 4 allowed specific accumulation of the carbohydrate radiotracer in galectin-1-overexpressing UMUC3 orthotopic tumors when imaged with PET. The 18F-labeled galactodendritic unit 4 was not found to accumulate in nontumor murine bladders. Conclusion: The 18F-labeled galactodendritic unit 4 and similar analogs may be clinically relevant and exploitable for PET imaging of galectin-1-overexpressing bladder tumors.
引用
- Pereira PMR, Roberts S, Figueira F, et al. PET/CT Imaging with an 18F-Labeled Galactodendritic Unit in a Galectin-1-Overexpressing Orthotopic Bladder Cancer Model. J Nucl Med. 2020. PMID: 32005776. doi:10.2967/jnumed.119.236430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。